International Isotopes Inc. Announces Company Name Change to Radnostix, Inc.

Mutual Termination of the Asset Purchase Agreement related to the Radnostix DUF6 Assets

Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown

Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio

Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025